ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Louis W Sullivan. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Louis W Sullivan reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:UTHR / United Therapeutics Corporation Director 0
US:EBS / Emergent BioSolutions Inc. Director 139,098
US:HSIC / Henry Schein, Inc. Director 10,811
US:BPAX / Director 10,000
US:EFX / Equifax Inc. Director 7,000
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Louis W Sullivan. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas ANIP / ANI Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ANIP / ANI Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Vendas Internas ANIP / ANI Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ANIP / ANI Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANIP / ANI Pharmaceuticals, Inc. Insider Trades
Compras Internas EBS / Emergent BioSolutions Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ANIP / ANI Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

EBS / Emergent BioSolutions Inc. Insider Trades
Vendas Internas EBS / Emergent BioSolutions Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ANIP / ANI Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2020-09-02 EBS SULLIVAN LOUIS W 20,525 111.2157 20,525 111.2157 2,282,702 265 56.61 -1,120,782 -49.10
2020-09-02 EBS SULLIVAN LOUIS W 7,893 111.2256 7,893 111.2256 877,904
2020-03-04 EBS SULLIVAN LOUIS W 7,893 58.9582 7,893 58.9582 465,357
2020-03-04 EBS SULLIVAN LOUIS W 7,893 58.9582 7,893 58.9582 465,357
2016-05-13 EBS SULLIVAN LOUIS W 4,131 39.0000 4,131 39.0000 161,109
2016-05-13 EBS SULLIVAN LOUIS W 21,600 39.1900 21,600 39.1900 846,504
2016-05-13 EBS SULLIVAN LOUIS W 21,600 39.2800 21,600 39.2800 848,448
2016-05-12 EBS SULLIVAN LOUIS W 300 39.0000 300 39.0000 11,700
2016-05-11 EBS SULLIVAN LOUIS W 9,969 39.2500 9,969 39.2500 391,283
2016-03-11 EBS SULLIVAN LOUIS W 14,879 34.0300 14,879 34.0300 506,332
2016-03-10 EBS SULLIVAN LOUIS W 14,820 35.3400 14,820 35.3400 523,739
2015-06-16 EBS SULLIVAN LOUIS W 13,457 31.3250 13,457 31.3250 421,541

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

EBS / Emergent BioSolutions Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Louis W Sullivan conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-12-23 2025-12-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -4,863 0 -100.00 512.34 -2,491,501
2025-12-23 2025-12-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,087 4,863 -18.27 511.22 -555,700 2,486,078
2025-12-23 2025-12-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 2,720 5,950 84.21 229.81 625,083 1,367,370
2025-12-23 2025-12-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 3,230 3,230 183.98 594,255 594,255
2025-07-28 2025-07-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 590 590
2025-05-02 2025-04-30 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 34,403 139,098 32.86
2024-12-19 2024-12-19 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
G - Gift -1,851 3,200 -36.65
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 5,051 -1.94 382.24 -38,224 1,930,719
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -800 5,151 -13.44 381.37 -305,099 1,964,456
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -944 5,951 -13.69 379.67 -358,412 2,259,441
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -400 6,895 -5.48 377.46 -150,984 2,602,587
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,700 7,295 -27.01 375.03 -1,012,581 2,735,844
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,962 9,995 -16.41 374.17 -734,115 3,739,796
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,525 11,957 -11.31 373.06 -568,914 4,460,659
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 13,482 -0.74 370.78 -37,078 4,998,856
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,926 13,582 -12.42 370.02 -712,649 5,025,546
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -752 15,508 -4.62 368.67 -277,238 5,717,306
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -100 16,260 -0.61 382.63 -38,263 6,221,564
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -620 16,360 -3.65 381.41 -236,475 6,239,876
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -700 16,980 -3.96 380.12 -266,084 6,454,438
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -200 17,680 -1.12 379.30 -75,860 6,706,024
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -500 17,880 -2.72 374.46 -187,228 6,695,263
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,200 18,380 -10.69 375.00 -825,007 6,892,555
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,451 20,580 -10.64 374.14 -917,008 7,699,725
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -200 23,031 -0.86 371.24 -74,249 8,550,144
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,501 23,231 -6.07 373.12 -560,048 8,667,874
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,400 24,732 -5.36 370.30 -518,413 9,158,136
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,100 26,132 -7.44 369.32 -775,563 9,650,953
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,307 28,232 -4.42 368.50 -481,632 10,403,548
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -600 29,539 -1.99 366.97 -220,184 10,840,001
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,121 30,139 -3.59 366.11 -410,407 11,034,120
2024-12-19 2024-12-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 31,260 92.25 175.43 2,631,450 5,483,942
2024-05-28 2024-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 17,430 104,695 19.97
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,979 13,060 -18.57 259.12 -771,918 3,384,106
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -2,181 16,039 -11.97 257.39 -561,366 4,128,270
2024-05-06 2024-05-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 5,160 18,220 39.51 119.76 617,962 2,182,027
2023-07-07 2023-07-07 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 880 13,060 7.22
2023-05-30 2023-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 33,847 87,265 63.36
2023-03-02 2023-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12,180 -5.43 245.10 -171,570 2,985,318
2023-03-02 2023-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12,880 5.75 132.30 92,610 1,704,024
2023-02-02 2023-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12,180 -5.43 261.33 -182,931 3,182,999
2023-02-02 2023-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12,880 5.75 132.30 92,610 1,704,024
2023-01-03 2023-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12,180 -5.43 276.26 -193,382 3,364,847
2023-01-03 2023-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X -700 12,880 -5.15 132.30 -92,610 1,704,024
2022-12-01 2022-12-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12,180 -5.43 279.89 -195,923 3,409,060
2022-12-01 2022-12-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12,880 5.75 132.30 92,610 1,704,024
2022-11-02 2022-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -700 12,180 -5.43 230.28 -161,196 2,804,810
2022-11-02 2022-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 700 12,880 5.75 132.30 92,610 1,704,024
2022-10-03 2022-10-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -710 12,180 -5.51 211.56 -150,208 2,576,801
2022-10-03 2022-10-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 710 12,890 5.83 132.30 93,933 1,705,347
2022-09-06 2022-09-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -4,910 12,180 -28.73 225.98 -1,109,550 2,752,407
2022-09-06 2022-09-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 4,910 17,090 40.31 101.80 499,838 1,739,762
2022-07-11 2022-07-08 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1,080 12,180 9.73
2022-07-08 2022-07-08 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 3,230 14,330 29.10
2022-05-31 2022-05-26 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 8,446 53,418 18.78
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -6,310 0 -100.00
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,345 11,100 -10.81 226.74 -304,963 2,516,795
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,500 12,445 -10.76 226.04 -339,063 2,813,091
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,766 13,945 -11.24 224.38 -396,250 3,128,939
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -1,699 15,711 -9.76 223.37 -379,506 3,509,366
2022-05-26 2022-05-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 6,310 17,410 56.85 76.36 481,832 1,329,428
2021-07-09 2021-07-08 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1,080 1,080
2021-07-09 2021-07-08 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 3,230 3,230 183.98 594,255 594,255
2021-06-28 2021-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1,680 0 -100.00
2021-06-28 2021-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1,680 11,100 17.83
2021-05-24 2021-05-20 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5,027 44,972 12.58
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15,000 0 -100.00
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15,000 0 -100.00
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15,000 9,420 -61.43 194.30 -2,914,500 1,830,306
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15,000 9,420 -61.43 194.30 -2,914,500 1,830,306
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 24,420 159.24 88.03 1,320,450 2,149,693
2021-05-12 2021-05-11 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 24,420 159.24 63.90 958,500 1,560,438
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -10,305 0 -100.00
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -3,118 39,945 -7.24 61.62 -192,131 2,461,411
2021-05-11 2021-05-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 10,305 43,063 31.46 18.64 192,085 802,694
2020-09-18 2020-09-16 4 EBS Emergent BioSolutions Inc.
Common Stock
G - Gift -10,004 32,758 -23.39
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise 7,893 15,786 100.00
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7,893 42,762 -15.58 111.23 -877,904 4,756,229
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7,893 50,655 18.46 20.08 158,491 1,017,152
2020-09-04 2020-09-02 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -20,525 42,762 -32.43 111.22 -2,282,702 4,755,806
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 5,160 5,160
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1,680 1,680
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise 0
2020-06-30 2020-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 2,300 9,420 32.30
2020-05-26 2020-05-21 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 2,821 63,287 4.67
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15,000 0 -100.00
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15,000 7,120 -67.81 90.54 -1,358,100 644,645
2020-03-27 2020-03-25 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 22,120 210.67 48.11 721,650 1,064,193
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -6,000 0 -100.00
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -6,000 7,120 -45.73 83.95 -503,700 597,724
2020-03-24 2020-03-23 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 6,000 13,120 84.27 54.77 328,620 718,582
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -7,893 0 -100.00 13.00 -102,609
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Employee Stock Options (Right to Buy)
M - Exercise -7,893 0 -100.00 14.71 -116,106
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7,893 60,466 -11.55 58.96 -465,357 3,564,967
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -7,893 60,466 -11.55 58.96 -465,357 3,564,967
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7,893 68,359 13.05 14.71 116,106 1,005,561
2020-03-06 2020-03-04 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7,893 68,359 13.05 13.00 102,609 888,667
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -1,000 10,000 -9.09
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -1,000 3,370 -22.88 115.04 -115,040 387,685
2020-01-21 2018-11-01 4/A UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1,000 4,370 29.67 54.77 54,770 239,345
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -3,750 0 -100.00
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 6,310 6,310
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 2,300 2,300
2019-06-28 2019-06-26 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 3,750 5,120 273.72
2019-05-28 2019-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5,736 60,466 10.48
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Stock Option (Right to Buy)
M - Exercise -7,893 0 -100.00
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Common Stock
F - Taxes -2,135 54,730 -3.75 49.41 -105,490 2,704,209
2019-05-09 2019-05-07 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 7,893 56,865 16.12 13.37 105,529 760,285
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 8,000 -11.11
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 1,370 -42.19 126.84 -126,840 173,771
2019-03-04 2019-03-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 2,370 72.99 54.77 54,770 129,805
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 9,000 -10.00
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 1,370 -42.19 115.83 -115,830 158,687
2019-02-04 2019-02-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 2,370 72.99 54.77 54,770 129,805
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 10,000 -9.09
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 1,370 -42.19 107.65 -107,650 147,480
2019-01-03 2019-01-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 2,370 72.99 54.77 54,770 129,805
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 11,000 -8.33
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 1,370 -42.19 119.53 -119,530 163,756
2018-12-04 2018-12-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 2,370 72.99 54.77 54,770 129,805
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X 1,000 12,000 9.09
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 1,370 -42.19 115.04 -115,040 157,605
2018-11-02 2018-11-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X -1,000 2,370 -29.67 54.77 -54,770 129,805
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 11,000 -8.33
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 3,370 -22.88 125.96 -125,960 424,485
2018-10-02 2018-10-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 4,370 29.67 54.77 54,770 239,345
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 12,000 -7.69
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 3,370 -22.88 119.45 -119,450 402,546
2018-09-05 2018-09-04 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 4,370 29.67 54.77 54,770 239,345
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 13,000 -7.14
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 3,370 -22.88 116.66 -116,660 393,144
2018-08-02 2018-08-01 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 4,370 29.67 54.77 54,770 239,345
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise X -1,000 14,000 -6.67
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer X -1,000 3,370 -22.88 113.81 -113,810 383,540
2018-07-05 2018-07-02 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 1,000 4,370 29.67 54.77 54,770 239,345
2018-06-28 2018-06-28 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1,620 0 -100.00
2018-06-28 2018-06-28 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1,620 3,370 92.57
2018-06-28 2018-06-26 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 3,750 3,750
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -15,000 0 -100.00
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -15,000 1,750 -89.55 108.50 -1,627,500 189,875
2018-06-06 2018-06-05 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 16,750 857.14 51.77 776,550 867,148
2018-05-24 2018-05-24 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4,895 48,972 11.11
2017-06-30 2017-06-28 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 4,210 4,210
2017-06-30 2017-06-28 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1,620 1,620
2017-06-22 2017-06-21 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
M - Exercise -1,750 0 -100.00
2017-06-22 2017-06-21 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 1,750 1,750
2017-05-26 2017-05-25 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 8,259 40,077 25.96
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 905 10,305 9.63
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 693 7,893 9.62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy) (Common Stock)
J - Other 693 7,893 9.62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
J - Other 693 7,893 9.62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Employee Stock Option (Right to buy)
J - Other 693 7,893 9.62
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 577 35,818 1.64
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 604 35,241 1.74
2017-05-26 2016-08-01 4 EBS Emergent BioSolutions Inc.
Common Stock
J - Other 152 34,637 0.44
2017-03-07 2016-06-21 4/A UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 4,910 4,910
2016-06-23 2016-06-21 4 UTHR UNITED THERAPEUTICS Corp
Restricted Stock Units
A - Award 1,750 1,750
2016-06-23 2016-06-21 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 5,000 5,000
2016-05-23 2016-05-19 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 5,985 34,485 21.00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 21,600 0 -100.00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 21,600 0 -100.00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 4,131 0 -100.00
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -21,600 28,500 -43.11 39.28 -848,448 1,119,480
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 21,600 50,100 75.79 11.67 252,072 584,667
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale 21,600 28,500 313.04 39.19 846,504 1,116,915
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 21,600 50,100 75.79 8.76 189,216 438,876
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -4,131 28,500 -12.66 39.00 -161,109 1,111,500
2016-05-16 2016-05-13 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 4,131 32,631 14.49 8.43 34,824 275,079
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise 300 4,131 7.83
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -300 28,500 -1.04 39.00 -11,700 1,111,500
2016-05-16 2016-05-12 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 300 28,800 1.05 8.43 2,529 242,784
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -9,969 4,431 -69.23
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -9,969 28,500 -25.91 39.25 -391,283 1,118,625
2016-05-13 2016-05-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 9,969 38,469 34.98 8.43 84,039 324,294
2016-04-04 2016-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 124 10,811 1.16
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -14,879 0 -100.00
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -14,879 28,500 -34.30 34.03 -506,332 969,855
2016-03-14 2016-03-11 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 14,879 43,379 52.21 10.28 152,956 445,936
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -14,820 14,879 -49.90
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -14,820 28,500 -34.21 35.34 -523,739 1,007,190
2016-03-14 2016-03-10 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 14,820 43,320 52.00 10.28 152,350 445,330
2016-03-07 2016-03-04 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1,103 14,096 8.49
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Stock Option (right-to-buy)
M - Exercise -7,898 0 -100.00
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -7,898 12,993 -37.81 168.63 -1,331,840 2,191,010
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 7,898 20,891 60.79 59.89 473,011 1,251,162
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -3,837 12,993 -22.80 168.50 -646,534 2,189,320
2016-03-03 2016-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -633 16,830 -3.62 168.93 -106,933 2,843,092
2016-01-21 2015-06-30 4/A HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 137 10,466 1.33
2016-01-04 2015-12-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 101 10,684 0.95
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Stock Option Right to Buy
M - Exercise -7,540 0 -100.00
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Stock Option Right to Buy
M - Exercise -6,137 0 -100.00
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -704 17,463 -3.88 154.48 -108,754 2,697,684
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1,241 18,167 -6.39 153.89 -190,977 2,795,720
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -2,300 19,408 -10.60 154.57 -355,511 2,999,895
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -5,240 21,708 -19.44 153.94 -806,646 3,341,730
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 7,540 26,948 38.85 51.23 386,274 1,380,546
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1,700 19,408 -8.05 154.58 -262,786 3,000,089
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -4,437 21,108 -17.37 153.95 -683,076 3,249,577
2015-11-19 2015-11-17 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 6,137 25,545 31.62 47.31 290,341 1,208,534
2015-10-01 2015-09-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 135 10,600 1.29
2015-09-29 2015-06-26 4/A UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 15,000 15,000
2015-07-02 2015-06-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 126 10,455 1.22
2015-06-29 2015-06-26 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
A - Award 15,000 15,000
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -15,000 15,000 -50.00
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
M - Exercise -30,000 0 -100.00
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -15,000 0 -100.00 185.60 -2,783,973
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 15,000 15,000 30.75 461,250 461,250
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
D - Sale to Issuer -30,000 0 -100.00 185.78 -5,573,400
2015-06-22 2015-06-18 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 30,000 30,000 41.14 1,234,200 1,234,200
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Stock Option
M - Exercise -13,457 29,699 -31.18
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Common Stock
S - Sale -13,457 28,500 -32.07 31.32 -421,541 892,762
2015-06-17 2015-06-16 4 EBS Emergent BioSolutions Inc.
Common Stock
M - Exercise 13,457 41,957 47.22 10.28 138,338 431,318
2015-05-21 2015-05-21 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 9,400 28,500 49.21
2015-04-01 2015-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 118 10,331 1.16
2015-03-31 2015-03-27 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -390 19,408 -1.97 138.80 -54,132 2,693,830
2015-03-10 2015-03-09 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -667 19,798 -3.26 138.97 -92,693 2,751,328
2015-03-04 2015-03-03 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1,317 20,465 6.88
2015-01-05 2014-12-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 118 10,214 1.17
2014-10-01 2014-09-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 155 10,110 1.56
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -13,862 0 -100.00
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -3,400 19,148 -15.08 120.32 -409,088 2,303,887
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -13,862 22,548 -38.07 119.91 -1,662,192 2,703,731
2014-09-02 2014-08-29 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 13,862 36,410 61.48 39.43 546,579 1,435,646
2014-07-02 2014-06-30 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 181 9,954 1.85
2014-06-27 2014-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15,000 15,000
2014-05-23 2014-05-22 4 EBS Emergent BioSolutions Inc.
Director Stock Option (right to buy)
A - Award 9,400 9,400
2014-05-23 2014-05-22 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 4,700 19,100 32.64
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise X -30,000 0 -100.00
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -4,900 0 -100.00 101.02 -494,983
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -25,100 4,900 -83.67 101.55 -2,548,845 497,583
2014-05-23 2014-05-22 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 30,000 30,000 31.17 935,100 935,100
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -500 6,137 -7.53
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -1,138 13,862 -7.59
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -500 22,548 -2.17 115.95 -57,975 2,614,441
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 500 23,048 2.22 47.31 23,655 1,090,401
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -1,138 22,548 -4.80 116.04 -132,054 2,616,470
2014-05-15 2014-05-13 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 1,138 23,686 5.05 39.43 44,871 933,939
2014-04-02 2014-03-31 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 134 9,816 1.38
2014-03-03 2014-02-27 4 HSIC HENRY SCHEIN INC
Deferred Compensation Plan Phantom Stock
A - Award 9,638 9,638
2014-03-03 2014-02-27 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 1,561 22,548 7.44
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -30,000 0 -100.00
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise -12,000 0 -100.00
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale -42,000 0 -100.00 78.48 -3,296,122
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 30,000 42,000 250.00 27.70 831,000 1,163,400
2013-10-01 2013-09-30 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise 12,000 12,000 24.39 292,680 292,680
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Stock Option (Right to Buy)
M - Exercise -15,000 0 -100.00
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
S - Sale -15,000 20,987 -41.68 103.91 -1,558,650 2,180,759
2013-08-21 2013-08-20 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
M - Exercise 15,000 35,987 71.47 35.49 532,350 1,277,179
2013-06-27 2013-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15,000 15,000
2013-05-24 2013-05-23 4 EBS Emergent BioSolutions Inc.
Director stock option (right to buy)
A - Award 7,200 7,200
2013-05-24 2013-05-23 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3,600 14,400 33.33
2013-03-12 2013-03-08 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
F - Taxes -1,346 20,987 -6.03 90.32 -121,571 1,895,546
2013-03-04 2013-03-01 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 2,086 22,333 10.30 88.84 185,320 1,984,064
2012-06-27 2012-06-26 4 UTHR UNITED THERAPEUTICS Corp
Share Tracking Award
A - Award 15,000 15,000
2012-05-21 2012-05-17 4 EBS Emergent BioSolutions Inc.
Director Stock Option (Right to buy)
A - Award 7,200 7,200
2012-05-21 2012-05-17 4 EBS Emergent BioSolutions Inc.
Common Stock
A - Award 3,600 10,800 50.00
2012-03-30 2012-03-30 4 BPAX BIOSANTE PHARMACEUTICALS INC
Non-Statutory Stock Option (right to buy)
A - Award 10,000 10,000
2012-03-30 2012-03-30 4 BPAX BIOSANTE PHARMACEUTICALS INC
Non-Statutory Stock Option (right to buy)
A - Award 25,000 25,000
2012-03-06 2012-03-02 4 HSIC HENRY SCHEIN INC
Common Stock, par value $0.01 per share
A - Award 2,536 20,248 14.32 73.12 185,432 1,480,534
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Stock Options
M - Exercise X -6,000 24,000 -20.00
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
S - Sale X -6,000 0 -100.00 63.93 -383,591
2011-01-03 2011-01-03 4 UTHR UNITED THERAPEUTICS Corp
Common Stock
M - Exercise X 6,000 6,000 24.39 146,340 146,340
2004-04-30 2004-04-28 4 EFX EQUIFAX INC
Stock Option/Right to Buy
A - Award 7,000 7,000 24.68 172,760 172,760
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)